Author/Authors :
Valizadeh، N نويسنده Assistant professor of Hematology/Medical Oncology, Urmia University of Medical Sciences, Emam Khomeini Hospital, Urmia, Iran. , , Noroozi، M نويسنده Assistant professor of Pediatric Hematology/Medical Oncology, Department of Pediatric hematology, Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran , , Hejazi، S نويسنده Assistant professor of Pediatric Hematology/Medical Oncology, Department of pediatric hematology, Motahari Hospital, Urmia University of Medical Sciences, Urmia , Iran. , , Nateghi، Sh نويسنده Medical Student, Urmia University of Medical sciences, Urmia, Iran , , Hashemi، A نويسنده Assistant professor of Gastroenterology, Urmia University of Medical Sciences, Urmia, Iran ,
Abstract :
Abstract Background Thalassemia patients that are conventionally treated by a regular transfusion regimen are exposed to blood born viral infections.The aim of this study was to investigate the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human Immunodeficiency virus (HIV) among all multitransfused thalassemia patients in west north of Iran. Material and Methods A retrospective study was conducted in February 2014, on 32 patients in Urmia, suffering from transfusion dependent thalassemia were admitted to Motahari and Emam Khomeini hospitals. Patients’ medical records were studied for HBs antigen and
seropositivity for HCV, and HIV antibodies. Results Out of 32transfusion dependent thalassemia patients aged between 5-17years, 18 (56.25%) and14 (43.75%) were male and female, respectively. All of them were found seronegative for HBs antigen, HCV, and HIV antibodies. Conclusion It seems that screening of blood products is efficient in Urmia, capital of West Azarbaijan, Iran for prevention of blood born viral infections.
